This inventor holds 1 USPTO granted patent. Top assignee: Universitè Catholique De Louvain. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Dominque Latinne: Innovator in Immune Response Modulation
Introduction
Dominque Latinne is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of immunology, particularly in the development of methods to inhibit T-cell mediated immune responses. His work is crucial for advancing treatments for various immune-related conditions.
Latest Patents
Dominque Latinne holds a patent for "Methods of inhibiting T-cell medicated immune responses." This invention relates to a LO-CD2a antibody and methods of using such antibodies or molecules that bind to the same epitope to prevent and inhibit an immune response in human patients. The administration of an effective amount of the LO-CD2a antibody is designed to prevent or inhibit graft rejection, graft versus host disease, or autoimmune disease. He has 1 patent to his name.
Career Highlights
Dominque Latinne is affiliated with Université Catholique de Louvain, where he conducts research and develops innovative solutions in immunology. His work has the potential to significantly impact patient care and treatment outcomes in the field of immune response modulation.
Collaborations
Dominque collaborates with Herve Bazin, who is also involved in research related to immune responses. Their partnership enhances the scope and depth of their research initiatives.
Conclusion
Dominque Latinne's contributions to immunology through his innovative patent demonstrate his commitment to advancing medical science. His work is vital for improving treatments for immune-related diseases and showcases the importance of research in this critical field.